Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19281
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMateo-Lozano, Silvia-
dc.contributor.authorBazzocco, Sarah-
dc.contributor.authorRodrigues, Paulo-
dc.contributor.authorMazzolini, Rocco-
dc.contributor.authorAndretta, Elena-
dc.contributor.authorDopeso, Higinio-
dc.contributor.authorFernández, Yolanda-
dc.contributor.authorDel Llano, Edgar-
dc.contributor.authorBilic, Josipa-
dc.contributor.authorSuárez-López, Lucía-
dc.contributor.authorMacaya, Irati-
dc.contributor.authorCartón-García, Fernando-
dc.contributor.authorNieto, Rocio-
dc.contributor.authorJimenez-Flores, Lizbeth M-
dc.contributor.authorde Marcondes, Priscila Guimarães-
dc.contributor.authorNuñez, Yaiza-
dc.contributor.authorAfonso, Elsa-
dc.contributor.authorCacci, Karina-
dc.contributor.authorHernández-Losa, Javier-
dc.contributor.authorLandolfi, Stefania-
dc.contributor.authorAbasolo, Ibane-
dc.contributor.authorRamón Y Cajal, Santiago-
dc.contributor.authorMariadason, John M-
dc.contributor.authorSchwartz, Simo-
dc.contributor.authorMatsui, Toshimitsu-
dc.contributor.authorArango, Diego-
dc.date2017-03-06-
dc.date.accessioned2018-09-13T00:23:24Z-
dc.date.available2018-09-13T00:23:24Z-
dc.date.issued2017-03-06-
dc.identifier.citationScientific Reports 2017; 7: 43702en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/19281-
dc.description.abstractAlthough deregulation of EPHB signaling has been shown to be an important step in colorectal tumorigenesis, the role of EPHB6 in this process has not been investigated. We found here that manipulation of EPHB6 levels in colon cancer cell lines has no effect on their motility and growth on a solid substrate, soft agar or in a xenograft mouse model. We then used an EphB6 knockout mouse model to show that EphB6 inactivation does not efficiently initiate tumorigenesis in the intestinal tract. In addition, when intestinal tumors are initiated genetically or pharmacologically in EphB6+/+ and EphB6-/- mice, no differences were observed in animal survival, tumor multiplicity, size or histology, and proliferation of intestinal epithelial cells or tumor cells. However, reintroduction of EPHB6 into colon cancer cells significantly reduced the number of lung metastasis after tail-vein injection in immunodeficient mice, while EPHB6 knockdown in EPHB6-expressing cells increased their metastatic spread. Consistently, although EPHB6 protein expression in a series of 130 primary colorectal tumors was not associated with patient survival, EPHB6 expression was significantly lower in lymph node metastases compared to primary tumors. Our results indicate that the loss of EPHB6 contributes to the metastatic process of colorectal cancer.en
dc.language.isoeng-
dc.titleLoss of the EPH receptor B6 contributes to colorectal cancer metastasis.en
dc.typeJournal Articleen
dc.identifier.journaltitleScientific Reportsen
dc.identifier.affiliationFunctional Validation &Preclinical Research (FVPR), Vall d'Hebron University Hospital, Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spainen
dc.identifier.affiliationGroup of Drug Delivery and Targeting, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital, Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spainen
dc.identifier.affiliationCIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Spainen
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Melbourne, Australiaen
dc.identifier.affiliationGroup of Biomedical Research in Digestive Tract Tumors, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital, Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spainen
dc.identifier.affiliationDepartment of Pathology, Vall d'Hebron Hospital, Barcelona, Spain (CIBERONC)en
dc.identifier.affiliationHematology, Department of Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japanen
dc.identifier.doi10.1038/srep43702en
dc.type.contentTexten
dc.identifier.pubmedid28262839-
dc.type.austinJournal Article-
dc.type.austinResearch Support, Non-U.S. Gov't-
local.name.researcherMariadason, John M
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

8
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.